Åke Nilsson
31 – 40 of 184
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Purification and characterization of human intestinal neutral ceramidase.
(
- Contribution to journal › Article
-
Mark
Response to Commentary on the effects of a ketogenic diet enriched with omega-3 polyunsaturated fatty acids on plasma phospholipid fatty acid profile in children with drug-resistant epilepsy
(
- Contribution to journal › Letter
-
Mark
Sphingolipids in the gut? Which are the important issues?
(
- Contribution to journal › Article
-
Mark
Sphingolipids, the diet, and the gut
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Delayed-release Multi Matrix System (MMX (TM)) mesalazine in ulcerative colitis - A viewpoint by Ake Nilsson
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Effects of bile diversion in rats on intestinal sphingomyelinases and ceramidase.
(
- Contribution to journal › Article
- 2006
-
Mark
Absorption and lipoprotein transport of sphingomyelin
(
- Contribution to journal › Scientific review
-
Mark
Ursolic acid and other pentacyclic triterpenoids stimulate intestinal alkaline sphingomyelinase in vitro
(
- Contribution to journal › Article
-
Mark
Optimizing management of distal ulcerative colitis.
(
- Contribution to journal › Scientific review
-
Mark
Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity
(
- Contribution to journal › Article